MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysarthria"

  • MDS Virtual Congress 2020

    Is acoustic speech analysis applicable for evaluation of swallowing impairment in patients with Parkinson’s disease (PD)?

    N. Madetko, S. Budrewicz (Wrocław, Poland)

    Objective: More than 80% of patients with Parkinson’s disease develop dysphagia during the course of the disease. Methods considered as ‘gold standard’ in swallowing evaluation…
  • MDS Virtual Congress 2020

    Noninvasive brain stimulation to treat hypokinetic dysarthria in PD: A sham stimulation-controlled trial

    I. Rektorova, L. Brabenec, P. Klobusiakova, M. Kostalova (Brno, Czech Republic)

    Objective: To treat hypokinetic dysarthria (HD) in PD patients using multiple sessions repetitive transcranial magnetic stimulation (rTMS) Background: Based on results from our rTMS exploratory…
  • MDS Virtual Congress 2020

    Levodopa induced changes of tongue body movements during speech production

    T. Thies, D. Mücke, R. Dano, M.. Barbe (Cologne, Germany)

    Objective: This study investigates the influence of levodopa (L-dopa) on tongue body movements during speaking. Background: Parkinson’s disease (PD) is a neurodegenerative disorder affecting non-motor…
  • MDS Virtual Congress 2020

    Speech biometrics can predict cerebellar dysfunction in multiple sclerosis

    A. Vogel, G. Noffs, F. Boonstra, T. Perera, S. Kolbe, J. Stankovich, H. Butzkueven, A. Evans, A. der Walt (Melbourne, Australia)

    Objective: To objectively describe cerebellar mediated speech function using a multiparameter index that reflects pathology and quality of life in MS. Background: Cerebellar function plays…
  • MDS Virtual Congress 2020

    Cross-linguistic exploration of speech treatment for Parkinson’s disease: is a universal speech treatment approach plausible?

    C. Fox (Tucson, AZ, USA)

    Objective: Examine speech treatment outcomes in people with Parkinson’s disease (PD) across different languages to explore the plausibility of a universal speech treatment approach. Background:…
  • MDS Virtual Congress 2020

    A Virtual Speech Therapist for Parkinson’s Disease

    A. Halpern, L. Ramig, R. Cole (Denver, CO, USA)

    Objective: This study was designed as a pilot investigation to explore the use of virtual therapy in the delivery of LSVT LOUD ® (Lee Silverman…
  • MDS Virtual Congress 2020

    LSVT LOUD Applied to Adults with Cerebral Palsy: Two Single-Subject Studies

    G. Moya-Gale, J. Galgano, C. Ferrone, Y. Chang, G. Tsang, L. Ramig (Brooklyn, NY, USA)

    Objective: To examine treatment-related acoustic and perceptual changes after LSVT LOUD ® in two adult speakers with dysarthria secondary to cerebral palsy (CP). Background: Cerebral…
  • MDS Virtual Congress 2020

    Increased Syllable Duration as a Marker for Dysarthria in Essential Tremor Patients with Deep Brain Stimulation

    H. Jergas, J.N Petry-Schmelzer, T. Thies, J. Steffen, H. Dafsari, D. Muecke, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To establish phonetic parameters that enable objectivation and measurability of stimulation-induced dysarthria (SID) in essential tremor (ET) patients with deep brain stimulation (DBS) in…
  • MDS Virtual Congress 2020

    The Unique Voiceprint Changed In Parkinson’s Disease

    F. XU (CHENGDU, China)

    Objective: To discover the unique voiceprint changed in patients with Parkinson’s disease. Background: Parkinson’s disease, PD, is a serious neurodegenerative disease affected millions old people…
  • MDS Virtual Congress 2020

    Speech is a sensitive marker in premanifest Huntington’s disease: exploring acoustic, cognitive and fine motor performance

    A. Vogel, J. Chan, Y. Lie, J. Stout (Melbourne, Australia)

    Objective: To explore the utility of objective analysis of speech as a quantifiable clinical biomarker in premanifest HD. Background: The autosomal dominant inheritance of Huntington’s…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley